Minocycline does not affect experimental pain or addiction-related outcomes in opioid maintained patients.

While these findings do not support minocycline's effects on OIH, minocycline may have a potential use as a cognitive enhancer for individuals with opioid use disorder, a finding that warrants further systematic studies.